15
2008© COPYRIGHT American Thrombosis & Hemostasis Network Maximizing Utilization of Lab Tracker Presenter: Ann Forsberg

2008© COPYRIGHT American Thrombosis & Hemostasis Network Maximizing Utilization of Lab Tracker Presenter: Ann Forsberg

Embed Size (px)

Citation preview

Page 1: 2008© COPYRIGHT American Thrombosis & Hemostasis Network Maximizing Utilization of Lab Tracker Presenter: Ann Forsberg

2008© COPYRIGHT

American Thrombosis & Hemostasis NetworkMaximizing Utilization of Lab TrackerPresenter: Ann Forsberg

Page 2: 2008© COPYRIGHT American Thrombosis & Hemostasis Network Maximizing Utilization of Lab Tracker Presenter: Ann Forsberg

2008© COPYRIGHT

2

ATHN…founded July, 2006

• Committed to One National Data Source for the Hemostasis and Thrombosis Community

• ATHN’s mission is to provide stewardship of a secure national database used to support – Outcomes analyses

– Research – Advocacy– Public Health

Page 3: 2008© COPYRIGHT American Thrombosis & Hemostasis Network Maximizing Utilization of Lab Tracker Presenter: Ann Forsberg

2008© COPYRIGHT

3

A Convergence of Needs

Knowledge that other countries (e.g., U.K., Sweden, Canada) have robust data sets

Recognition of Need for…

data safety, portability, back-upclinical outcomes data

evidence-based clinical standards ONE national clinical database consolidate/conserve resources

Adoption of Lab Tracker

2000 development2002 rollout

2003 UDC forms2005 as national tool2005-8 web version

Page 4: 2008© COPYRIGHT American Thrombosis & Hemostasis Network Maximizing Utilization of Lab Tracker Presenter: Ann Forsberg

2008© COPYRIGHT

4

ATHN’s Strategic DirectionWays HTCs Utilize Database in Lab Tracker

Network Infrastructure

Outcomes Improvement

Public Health and Safety

Outcomes Improvement

Data Analysis and Research

Use data to drive quality, service, and patient centered care

Page 5: 2008© COPYRIGHT American Thrombosis & Hemostasis Network Maximizing Utilization of Lab Tracker Presenter: Ann Forsberg

2008© COPYRIGHT

5

Maximizing Uses of LabTracker

•Collection of data for clinical management and evaluation

•Collection of national outcome data

•Outcome improvement

•Expansion of data collection for other disease groups

• International harmonization

Page 6: 2008© COPYRIGHT American Thrombosis & Hemostasis Network Maximizing Utilization of Lab Tracker Presenter: Ann Forsberg

2008© COPYRIGHT

6

Outcome Data

Public Health Departments

Medicare/Medicaid

Insurance Companies

MCHB/CDC

340B Programs

Granting Agencies

PatientsConsumer Organizations

Regulatory Agencies

Recognized need to provide health outcome data:

Page 7: 2008© COPYRIGHT American Thrombosis & Hemostasis Network Maximizing Utilization of Lab Tracker Presenter: Ann Forsberg

2008© COPYRIGHT

7

Types of Outcomes

• Measure and improve integrated patient care services

• Measure and improve health outcomes

Page 8: 2008© COPYRIGHT American Thrombosis & Hemostasis Network Maximizing Utilization of Lab Tracker Presenter: Ann Forsberg

2008© COPYRIGHT

8

Care Provision Performance CF

• Guidelines recommend evaluation at an accredited CF center quarterly

• Standardized Measures– Pulmonary testing semiannually– Culture of respiratory secretions semiannually

Our Center Top 10 Centers US Average

In Children with normal Lung Function 72% 86% 56%In Children with abnormal Lung Function 70% 91%

64%n Adults with mild disease 47% 74% 41%In Adults with moderate to severe disease 75% 83%

3%

Page 9: 2008© COPYRIGHT American Thrombosis & Hemostasis Network Maximizing Utilization of Lab Tracker Presenter: Ann Forsberg

2008© COPYRIGHT

9

Our Center Top 10 Centers US Average

Lung Function in Children 6 to 12 years

104% 103% 92%

Lung Function in Children 13 to 17 years

88% 96% 85%

Lung Function in Adults 18 to 30 years

77% 78% 65%

Lung Function in Adults older than 30 years

59% 64% 52%

Median BMI percentile patients 2 to 20 years

52% 58% 44%

Median BMI for patients older than 21 years

22 k/m2 21 k/m2 21 k/m2

Proportion of Children in nutritional failure

17.1% 17.8% 32.3%

Proportion of Adults in nutritional failure

29% 25% 42%

Performance measures for CF Outcomes

Page 10: 2008© COPYRIGHT American Thrombosis & Hemostasis Network Maximizing Utilization of Lab Tracker Presenter: Ann Forsberg

2008© COPYRIGHT

10

National Collection of Health Indicators

•Hemophilia Data Set

•Universal Data Collection

•MCHB Indicators

–Performance Measure 7 (Family participation)

–Form 5 (Insurance coverage and demographics)

Page 11: 2008© COPYRIGHT American Thrombosis & Hemostasis Network Maximizing Utilization of Lab Tracker Presenter: Ann Forsberg

2008© COPYRIGHT

11

Maximizing Lab Tracker - Care Performance

• Templates for national outcome reportsCenter and regional comparisons of service utilization

Comprehensive care visitsDiagnostic services

Number of diagnostic services performedAge of diagnosis

Genetic services/testingProvider contacts Patient follow-upPatients on prophylaxisPatients on home therapy

Page 12: 2008© COPYRIGHT American Thrombosis & Hemostasis Network Maximizing Utilization of Lab Tracker Presenter: Ann Forsberg

2008© COPYRIGHT

12

Maximizing Labtracker - Health Indicators

Mortality ratesJoint diseaseSurgical interventionsDevelopment of inhibitorsCo-morbidities Emergency room visitsObesity

Page 13: 2008© COPYRIGHT American Thrombosis & Hemostasis Network Maximizing Utilization of Lab Tracker Presenter: Ann Forsberg

2008© COPYRIGHT

13

Performance Improvement of US HTCs

• Standards and Criteria for the Care of Persons with Hemophilia (MASAC 2002)

Page 14: 2008© COPYRIGHT American Thrombosis & Hemostasis Network Maximizing Utilization of Lab Tracker Presenter: Ann Forsberg

2008© COPYRIGHT

14

What is an HTC?

National HTC Survey •Implemented by Regional Coordinators byeSurvey linked to ATHN website•Descriptive data extracted from HDS and provided by HTC staff

– Staff mix and experience– Impatient services – Outreach efforts– Laboratory services– Demographics

Page 15: 2008© COPYRIGHT American Thrombosis & Hemostasis Network Maximizing Utilization of Lab Tracker Presenter: Ann Forsberg

2008© COPYRIGHT

15

In the Future

• Expansion of data elements for bleeding disorders

• Expansion to include thrombotic disorders

• International harmonization